Krebs Biochemicals & Industries Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 114.61 million compared to INR 191.58 million a year ago. Revenue was INR 116.54 million compared to INR 199.5 million a year ago. Net loss was INR 69.4 million compared to INR 113.14 million a year ago. Basic loss per share from continuing operations was INR 3.07 compared to INR 5.39 a year ago. Diluted loss per share from continuing operations was INR 3.07 compared to INR 5.39 a year ago.
For the full year, sales was INR 521.34 million compared to INR 597.03 million a year ago. Revenue was INR 527.55 million compared to INR 608.59 million a year ago. Net loss was INR 246.92 million compared to INR 445.27 million a year ago.